
Cipher Pharmaceuticals Inc
TSX:CPH

Wall Street
Price Targets
CPH Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CPH
is 19.15 CAD
with a low forecast of 14.65 CAD and a high forecast of 26.25 CAD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Cipher Pharmaceuticals Inc
For the last 8 years the
compound annual growth rate for
Cipher Pharmaceuticals Inc's operating income is
-5%.
The projected
CAGR
for the next 6 years is
-5%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CPH's stock price target?
Price Target
19.15
CAD
According to Wall Street analysts, the average 1-year price target for
CPH
is 19.15 CAD
with a low forecast of 14.65 CAD and a high forecast of 26.25 CAD.
What is Cipher Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
29%
For the last 8 years the
compound annual growth rate for
Cipher Pharmaceuticals Inc's revenue is
1%.
The projected
CAGR
for the next 2 years is
29%.
What is Cipher Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-5%
For the last 8 years the
compound annual growth rate for
Cipher Pharmaceuticals Inc's operating income is
-5%.
The projected
CAGR
for the next 6 years is
-5%.
What is Cipher Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
16%
The
compound annual growth rate
of Cipher Pharmaceuticals Inc's net income for the next 3 years is
16%.